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Background: Genome-wide association studies (GWAS) have reported that the polymorphism rs5219 of the potassium
inwardly rectifying channel, subfamily J, member 11 (KCNJ11) is associated with type 2 diabetes mellitus (T2DM). Given
that diabetic retinopathy (DR) is one of the most common microvascular complications of T2DM, GWAS have identified
a number of potential susceptibility genes for DR. However, only a fraction of them have been replicated in different
studies and show consistent genetic associations with the occurrence of DR. The aim of the present study was to
investigate whether common variants of KCNJ11 confer DR in a cohort of the Chinese Han population.
Methods: A case–control study of 580 T2DM patients, including 105 T2DM with DR and 475 T2DM without DR
was performed. A single nucleotide polymorphism (SNP) of KCNJ11 (rs5219) was genotyped, and its association
with DR was explored using a dominant genetic model. Genotyping was performed by iPLEX technology. Univariate
and multivariate logistic regression (MLR) analysis controlling for confounders was conducted to evaluate the association
between rs5219 and DR.
Results: The A allele frequency of rs5219 was significantly higher in DR patients than that in the patients without DR
(49.01% versus 38.68%, P <0.05). We found the minor A allele could increase the risk to develop DR (ORint = 1.58,
95% CI: 1.139 to 2.192 for allele and P = 0.006, ORint = 1.607, 95% CI: 1.267 to 2.038 for genotype and P <0.001) in
the Chinese Han population.
Conclusions: Our findings provided evidence that KCNJ11 was associated with DR in Chinese Han patients with T2DM.
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Type 2 diabetes mellitus (T2DM) is a multifactorial meta-
bolic syndrome, characterized by insulin resistance and/or
pancreatic β-cell dysfunction resulting from both genetic
and environmental factors [1,2]. Its prevalence has in-
creased rapidly over the last decade owing to human
longevity and a surge of obesity in a lot of countries [3],
which causes great economic impact on individuals,
families, and health systems worldwide.* Correspondence: wenjie065@126.com
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unless otherwise stated.Diabetic retinopathy (DR), one of the most common
microvascular complications of T2DM, is a leading cause
of acquired visual loss in working-age individuals [4,5].
Blindness develops primarily from either increased DME
(diabetic macular edema) or proliferation of new retinal
vessels [6]. Major risk factors, such as prolonged duration
diabetes, poor control of blood glucose and high blood
pressure have been considered to be responsible for the
onset and progression of DR [7,8]. Nevertheless, these
factors do not account completely for the risk of DR.
Familial aggregation and the various incidence attributed
to the diverse ethnic backgrounds suggest the existence of
an heritable component in DR, independent of glycemic
control and duration of T2DM [9].s is an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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sizes conducted in Mexican-American, Chinese, and
Caucasian populations indicated that several SNPs or
loci had borderline or weak associations with DR in either
type 1 or type 2 diabetes mellitus [10-13]. Although sev-
eral candidate gene studies had reported promising genes
of DR, only few of them had been replicated and showed
evident genetic associations.
The potassium inwardly rectifying channel, subfamily J,
member 11 (KCNJ11) is a pore-forming subunit of ATP-
sensitive potassium (KATP) channels in pancreatic β-cells
[14] and plays a critical role in the regulation of insulin
secretion [15]. The KATP channels consist of four subunits
of the inwardly rectifying potassium channel Kir6.2 and
four subunits of the sulfonylurea receptor 1 (SUR1), which
are targets of sulfonylurea drugs. Variations of KCNJ11
could contribute to the decreased sensitivity of the ion
channel to ATP, leading to more ATP consumption, which
further contributes to insulin-release impairment. E23K
(rs5219) in the KCNJ11 gene, substituting glutamate for
lysine at position 23, is identified as a SNP associated with
T2DM susceptibility [16]. In addition, it has been reported
that KCNJ11 is associated with the therapeutic response
to sulfonylureas because of its regulation function of in-
sulin secretion [17]. Based on the reported association
between KCNJ11 polymorphisms and T2DM, we hypothe-
sized that this gene could also be related to the risk of
DR.
Up to now, none of the risk genes of T2DM contribut-
ing to the susceptibility of DR had been reported. The aim
of the present study was to investigate whether the genetic
variant (rs5219) of KCNJ11 confers DR in a Chinese Han
population with T2DM.Methods
Study population
Our study involved 580 Chinese patients who resided in
the metropolitan area of Shanghai and had been diagnosed
with T2DM. T2DM was diagnosed on the basis of the
WHO criteria (1999) [18]. Known subtypes of diabetes
were excluded based on antibody measurements and in-
heritance. Patients with diabetic ketoacidosis or ketonuria
also were excluded. All the patients underwent digital
non-mydriatic fundus photography, and two certified oph-
thalmologists diagnosed DR. Patients without DR were se-
lected as controls. All study participants registered in the
analysis were recruited from the Endocrinology and Me-
tabolism outpatient clinics at Fudan University Huashan
Hospital in Shanghai. All subjects provided written in-
formed consent for participation in the study and do-
nation of samples. The Ethics Committee of Huashan
Hospital affiliated with Fudan University approved this
protocol.Measurement
All participants were interviewed for the documentation
of medical histories, medications, regular physical exam-
inations, and laboratory assessment of T2DM risk factors.
Physician-obtained systolic and diastolic blood pressure
(BP) values were taken on the left arm of the seated partici-
pants. All participants underwent a complete hematological
examination while fasting, including serum total cholesterol
(TC), triglyceride (TG), blood urea nitrogen (BUN), uric
acid (UA), and C-peptide (CP) levels that were measured
by an enzymatic method with a chemical analyzer (Hitachi
7600–020, Tokyo, Japan). Postprandial plasma glucose
(PPG) was measured 2 h after eating. Fasting plasma
glucose(FPG) was measured in fasting state. The blood
was centrifuged at 3,000 rpm for 10 min for plasma separ-
ation and immediately used to measure biomarkers.
Serum creatinine (Cr) was measured by radioimmuno-
assay (Beijing Atom High-Tech Co. Ltd.). FPG and PPG
were quantified by the glucose oxidase-peroxidase pro-
cedure. Glycated hemoglobin (HbA1c) was estimated
by high-pressure liquid chromatography using an analyzer
(HLC-723G7, Tosoh Corporation, Japan). The day-to-day
and interassay coefficients of variation at the central la-
boratory in our hospital for all analyses were between 1%
and 3%.
Definition
Diabetes was defined as a self-reported history of physician-
diagnosed T2DM or according to 1999 WHO criteria [18],
which consisted of one of the following: fasting plasma
glucose FPG ≥7.0 mmol/L, plasma glucose ≥11.1 mmol/L
2 hours after an oral glucose tolerance test (OGTT), or
random plasma glucose ≥11.1 mmol/L. All the T2DM pa-
tients were tested for DR using digital non-mydriatic fun-
dus photography and image analysis. Fundus photography
was performed at each site following a standardized proto-
col. Both eyes of each participant were photographed with
a 45-degree 6.3-megapixel digital non-mydriatic camera
(Canon CR6-45NM, Lake Success, NY), repeated only
once if necessary. DR was determined by two independ-
ent retinal specialists without knowledge of patient clinical
details. The patients were classified according to the pres-
ence or absence of DR, regardless of its degree of severity.
The duration was defined as the interval between the first
diagnosis of diabetes and the time of enrollment in the
present study. Age of onset year was the age at which an
individual was diagnosed with T2DM for the first time.
The clinical characteristics of participants are summarized
in Table 1.
SNP genotyping
Peripheral venous blood samples were collected from all
participants and the genomic DNA was isolated from
venous blood leukocytes by the conventional phenol/
Table 1 Baseline characteristics of subjects
Total sample With DR Without DR P value
Demographic information
Number 580 475 105 -
Age (year) 64.73 ± 10.85 64.77 ± 10.96 64.54 ± 10.33 0.78
Sex (% female) 362(62.31%) 299(62.82%) 63(60%) 0.25
Height (cm) 160.39 ± 8.80 160.37 ± 8.82 160.48 ± 8.77 0.88
Weight (kg) 64.18 ± 10.64 64.25 ± 10.74 63.87 ± 10.19 0.64
SBP (mmHg) 138.76 ± 20.90 138.21 ± 21.25 141.20 ± 19.12 0.06
DBP (mmHg) 81.94 ± 11.51 81.94 ± 11.07 81.93 ± 13.31 0.99
Laboratory essays
FPG (mmol/l) 8.69 ± 3.11 8.34 ± 2.75 10.28 ± 4.01 <0.001
CP0 (ug/l) 3.69 ± 2.13 3.71 ± 2.16 3.58 ± 1.98 0.40
PPG (mmol/l) 14.76 ± 5.71 14.01 ± 5.37 18.13 ± 5.98 <0.001
TC (mmol/l) 5.36 ± 1.11 5.35 ± 1.09 5.37 ± 1.18 0.85
TG (mmol/l) 1.97 ± 1.37 1.95 ± 1.36 2.04 ± 1.45 0.40
HbAlc (%) 7.18 ± 1.57 6.97 ± 1.40 8.12 ± 1.92 <0.001
BUN (mmol/l) 6.10 ± 1.63 6.05 ± 1.53 6.34 ± 1.99 0.02
CR (μmol/l) 67.39 ± 22.33 66.72 ± 20.05 70.43 ± 30.46 0.03
UA (mmol/l) 0.29 ± 0.08 0.29 ± 0.08 0.28 ± 0.08 0.06
Medical history
Duration (year) 7.38 ± 6.20 7.09 ± 6.13 8.67 ± 6.39 0.001
Age of onset year 57.57 ± 10.79 57.91 ± 10.80 56.04 ± 10.62 0.02
KCNJ11 (rs5219 A%) 231(40.51%) 181(38.68%) 50(49.01%) 0.004
BUN, blood urea nitrogen; CP0, 0 h C-peptide; Cr, creatinine; DBP, diastolic blood pressure; DR, diabetic retinopathy; FPG, fasting plasma glucose; PPG, postprandial
plasma glucose; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride; UA, uric acid.
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KCNJ11 was genotyped using iPLEX (Sequenom, San
Diego, CA, USA) with detection by the matrix-assisted
laser desorption/ionization time-of-flight mass spectrom-
etry platform. The with-DR and without-DR groups were
mixed for genotyping. There was a 99.9% genotype con-
cordance rate when duplicated samples were compared
across plates.
Statistical analysis
Continuous variables were detected by the Kolmogorov-
Smirnov Test according to whether they followed normal
distribution. Variables that were not normally distributed
were log-transformed to approximate normal distribution
for analysis. Results are described as mean ± SD or median
unless stated otherwise. Differences in variables between
the with-DR group and the with-DR group were deter-
mined by unpaired t-test. Between groups, differences in
properties were accessed by χ2 analysis. Univariate logistic
regression was performed to determine variables associ-
ated with DR and to estimate confounding factors pos-
sibly disturbing the relation of genetic variants to DR.Multivariable logistic regression (MLR) was carried out
to control potential confounders for determining inde-
pendent contribution of variables to DR. In order to better
investigate interaction between DR and genetic variants of
KCNJ11, we performed two analyses according to the vari-
ables of allele and genotype of KCNJ11, respectively. Odds
ratios (OR) with 95% confidence intervals (CI) were calcu-
lated for the relative risk of genetic variants of KCNJ11
with DR. Results were analyzed using the Statistical
Package for Social Sciences for Windows version 16.0
(SPSS, Chicago, IL, USA). Tests were two-sided and a P
value of <0.05 was considered significant.
Results
Clinical characteristics of subjects
The baseline clinical characteristics of the 580 subjects
were listed in Table 1. There are 176 males and 299 females
(mean age, 64.77 ± 10.9 years) in control and 42 males and
63 females (mean age, 64.54 ± 10.33 years) in case. DR pa-
tients had more weight than non-DR patients. The variables
of FPG, PPG, HbAlc, BUN and Cr levels were significantly
higher in cases than in controls (P <0.05 for all). In
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T2DM and earlier onset of T2DM in with-DR group as
compared with the without-DR group (P <0.05 for all).
Other variables of age, sex, height, weight, SBP, DBP, CP,
TC, TG, UA was similar between the two groups (P >0.05
for all). The minor allele (A) frequency of rs5219 was
38.68% and 49.01% in controls and cases, respectively.
The prevalence of DR was 14.67% and 23.21% in diabetic
patients with G and A allele, respectively (Figure 1). The
prevalence of DR was 14.47%, 16.85% and 28.57% in dia-
betic patients with GG, GA and GG genotype, respectively
(Figure 2).Univariate logistic regression analysis for diabetes
To estimate the association of various clinical factors and
DR, univariate logistic regression models were developed
to include age, sex, BMI, hypertension, lipid profiles, renal
function parameters and SNP (rs5219) (Table 2). The uni-
variate logistic analyses indicated that FPG, PPG, HbAlc,
BUN, Cr, duration of T2DM, onset age of T2DM were sig-
nificantly associated with DR (P <0.05 for all). In subjects
with MAF of rs5219 in KCNJ11, the OR for DR was 1.524
(95% CI: 1.123 to 2.069, P = 0.007).Multiple logistic regression analysis for diabetes
MLR demonstrated that the genetic variant (rs5219) of
KCNJ11 remained significantly different between case and
control after adjustment for potential confounders (P =
0.006 for allele analysis and P <0.001 for genotype analysis,
Table 3). After adjusting for confounding factors, in sub-
jects with minor allele frequency (MAF) of rs5219 in
KCNJ11, the OR for DR was 1.580 (95% CI: 1.139 to 2.192).Figure 1 The prevalence of diabetic retinopathy (DR) in two
groups according to allele of rs5219.Discussion
We conducted a case–control study to evaluate the asso-
ciation between KCNJ11 (rs5219) and T2DM in a cohort
of a Chinese Han population with T2DM. To our know-
ledge, this study is the first to find that the T2DM-
susceptibility gene polymorphism (KCNJ11 rs5219) is
associated with an increased risk of DR (P = 0.006 for
allele analysis and P <0.001 for genotype analysis).
T2DM is a complex and multifactorial disease resulting
from a complex interaction between genes and environ-
mental factors, whose microvascular and macrovascular
complications are highly prevalent among T2DM patients.
DR is one of the most common and specific microvascular
complications of T2DM, which is considered to be in-
fluenced by hereditary [19,20] and environmental factors
[21,22]. Given that DR is one of the leading risk factors
and causes of blindness worldwide [23], the identification
of risk factors for DR could lead to a decrease in vision
loss associated with T2DM.
Attempting to identify risk genes of DR, numerous
studies have been conducted over the past few decades
[17]. Using candidate gene analysis and GWAS, investi-
gators have identified a number of potential susceptibil-
ity genes of DR. Several biochemical pathways, including
formation of advanced glycation end products (AGEs),
polyol accumulation, activation of protein kinase C, oxida-
tive stress and so on, have been proposed to mediate the
pathogenesis of DR [24]. At present, three candidate genes
of DR that have been extensively studied are vascular
endothelial growth factor (VEGF), aldose reductase (ALR),
and the receptor for advanced glycation end products
(RAGE) [24,25].
Protein encoded by KCNJ11 has a crucial function in
insulin secretion, thus making it a potential susceptibility
gene of T2DM. The rs5219 variant of KCNJ11 has been
widely reported to be associated with T2DM in various eth-
nic populations [26-28]. This gene encodes for the Kir6.2
subunit, which forms the KATP channels with the regulatory
subunit sulfonylurea receptor 1 (SUR1). These channels are
present in many tissues, including heart, vascular smooth
muscles, and vascular endothelial cells [29] and play
important roles in responses to stress [29], blood pressure
regulation [30] and the physiology and pathophysiology of
various tissues by coupling the metabolic state of the cells
with cellular electrical activity [31].
On this basis, interestingly, a strong association is found
between the common variant of KCNJ11 (rs5219) with DR
in our study (P = 0.006 for allele analysis and P <0.001 for
genotype analysis), which has not been reported in previous
studies. The associations between variants of KCNJ11 and
hypertension were demonstrated in Chinese [32] and
Korean populations [27], suggesting a possible role of
KCNJ11 in macrovascular diseases. As DR is one of micro-
vascular complications of T2DM, a hypothesis that KCNJ11
Figure 2 The prevalence of diabetic retinopathy (DR) in three groups according to genotype of rs5219.
Table 2 Univariate analysis for risk factors of diabetic
retinopathy
Variables Β S.E. P value OR 95% CI
Age −0.002 0.007 0.781 0.998 0.984-1.012
Sex −0.119 0.156 0.446 0.888 0.654-1.206
BMI −0.015 0.023 0.511 0.985 0.942-1.030
SBP 0.007 0.004 0.062 1.007 1.000-1.014
DBP 0.001 0.007 0.997 1.001 0.987-1.013
FPG 0.171 0.023 <0.001 1.186 1.135-1.240
CP0 −0.033 0.039 0.398 0.968 0.897-1.044
PPG 0.125 0.014 <0.001 1.133 1.103-1.165
TC 0.013 0.069 0.849 1.013 0.885-1.160
TG 0.044 0.052 0.402 1.045 0.943-1.158
HbAlc 0.407 0.046 <0.001 1.502 1.373-1.643
BUN 0.103 0.044 0.019 1.109 1.017-1.209
CR 0.006 0.003 0.034 1.006 1.000-1.012
UA −2.076 1.057 0.058 0.125 0.016-1.006
Duration 0.037 0.011 0.001 1.038 1.015-1.061
Age of onset −0.016 0.007 0.023 0.984 0.971-0.998
Family history of DM −0.201 0.160 0.209 0.818 0.598-1.119
Alcohol −0.842 0.444 0.058 0.431 0.181-1.028
*rs5219 A/G 0.421 0.156 0.007 1.524 1.123-2.069
*rs5219 genotype 0.432 0.112 <0.001 1.540 1.236-1.920
*KCNJ11.
BUN, blood urea nitrogen; CP0, 0 h C-peptide; Cr, creatinine; DBP, diastolic
blood pressure; DR, diabetic retinopathy; FPG, fasting plasma glucose; PPG,
postprandial plasma glucose; SBP, systolic blood pressure; TC, total cholesterol;
TG, triglyceride; UA, uric acid.
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ing implies that KCNJ11 (rs5219) may disturb DR suscep-
tibility. However, the molecular mechanisms are yet to be
expounded.
To date, there were no consistent and definitive genetic
associations with DR in the literature, likely due to the
complexity and multifactorial etiology of DR: both genetic
and environmental factors play critical roles in its develop-
ment and progression. Most published studies were based
on small patient samples, and their case definitions were
not based on the widely accepted and standardized cri-
teria. In our study, we used the method of non-mydriatic
digital stereoscopic retinal imaging (NMDSRI) for screen-
ing and diagnosing DR. NMDSRI is a sensitive and specific
method for the screening and diagnosis of diabetic ret-
inopathy, which may help improve compliance with the
standards of eye care for patients with T2DM [33].
Several limitations of this study deserve comment. First,
the subjects who participated in the study were recruited
from Shanghai, so they may not have been representative
of China as a whole. Second, we need a larger sample to
further validate the effect of the polymorphism on DR risk
among different ethnic populations. In addition, our study
focused primary analyses on a comparison of patients with
DR to patients without DR rather than comparing thoseTable 3 Multiple analysis for risk factors of diabetic
retinopathy
Variables Β S.E. P value OR 95% CI
KCNJ11 (rs5219 A/G )a 0.458 0.167 0.006 1.580 1.139-2.192
KCNJ11 (rs5219 genotype )a 0.474 0.121 <0.001 1.607 1.267-2.038
aadjusted for variables of Age, Sex, BMI, SBP, FPG, PPG, TC, TG, HbA1c,
Duration, age of onset, Family history of DM and alcohol.
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vanced DR. The possibility of an overlap with other causes
of retinopathy may have limited the proper identification
of DR genes in mild stages of the disease.
Conclusions
In summary, we identified the AA genotype or A allele
of KCNJ11 (rs5219) as a genetic risk factor for DR in
T2DM patients. Further confirmatory studies on the func-
tional effect of KCNJ11 variants should be conducted to
reveal its real contribution to T2DM.
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